Vor Biopharma Inc.
VOR | NASDAQ
$22.76
+$0.87 (+3.97%)
Sep 22, 2026, 1:39 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -62.81M | -219.59M | 1.72B | -812.68M | -1.57B | -32.49M | -30.71M | -27.56M | -27.84M | -30.8M | -26.26M | -33.19M | -29.98M | -28.43M | -23.91M | -23.79M | -21.66M | -22.74M | -18.25M | -18.55M | -18.37M | -13.72M |
Depreciation & Amortization | 36K | 28K | -40K | 2K | 2.04M | 825K | 865K | 820K | 869K | 943K | 892K | -1.42M | 870K | 837K | 632K | -419K | 1.89M | 426K | 395K | 1.13M | 354K | 311K |
Stock-Based Compensation | 9.4M | 8.87M | 8.95M | 8.03M | 1.84M | 1.93M | 1.71M | 2.26M | 2.79M | 3.08M | 1.89M | 3.16M | 4.24M | 4.07M | 3.88M | 3.33M | 1.74M | 1.75M | 1.2M | n/a | 1.07M | 891K |
Other Working Capital | 6.44M | -6.44M | -3.05M | 56K | 4.63M | -1.27M | 2.82M | -584K | 857K | -1.64M | -779K | -1.39M | 838K | -677K | -1.2M | -518K | -6.1M | -2.6M | -1.83M | -2.2M | -802K | -3.01M |
Other Non-Cash Items | 12.45M | 187.98M | -1.76B | 745.93M | 1.53B | 1.3M | 1.26M | 1.29M | 922K | 435K | 228K | -3.16M | -67K | -63K | 2.25M | 2.49M | -865K | 985K | 893K | 1.19M | 1.19M | 322K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 15.24M | -15.54M | 3.16M | 5.06M | 4.63M | -2.64M | 2.82M | -99K | 1.41M | -4.12M | -779K | 1.27M | 838K | -677K | -1.2M | -518K | -6.1M | -3.32M | -1.83M | -1.11M | -802K | -5.45M |
Operating Cash Flow | -25.67M | -38.25M | -22.8M | -53.66M | -35.18M | -31.07M | -24.06M | -23.29M | -21.85M | -30.47M | -24.03M | -27.9M | -24.1M | -24.27M | -18.35M | -18.9M | -24.99M | -22.9M | -17.59M | -17.34M | -16.57M | -17.65M |
Capital Expenditures | -120K | -48K | -314K | -244K | -152K | -231K | -72K | -34K | -9K | -114K | -111K | -465K | -399K | -94K | -321K | -298K | -5.83M | -2.01M | -1.17M | -636K | -919K | -1.17M |
Cash Acquisitions | n/a | n/a | -799K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -41K | n/a | n/a | 96.72K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -79M | -276.5M | -53.66M | n/a | n/a | n/a | n/a | n/a | -1K | -9.91M | -16.55M | 1K | -34.96M | -23.41M | -118.15M | n/a | n/a | -5.04M | -4.79M | -7.85M | -75.12M | n/a |
Sales Maturities Of Investments | 42.59M | 13.31M | 5M | n/a | -1K | 1K | n/a | n/a | 53M | 54M | 27M | 41M | 49M | 30M | 21.43M | 13M | 3.13M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 799K | n/a | 799K | n/a | n/a | n/a | n/a | n/a | n/a | 41K | n/a | n/a | -96.72K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -36.53M | -263.24M | -48.97M | -244K | 646K | -230K | -72K | -34K | 52.99M | 43.97M | 10.34M | 40.54M | 13.64M | 6.5M | -97.04M | 12.7M | -2.7M | -7.06M | -5.95M | -8.49M | -76.04M | -1.17M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -106K | -2K | -131K | -19K | -32K | -55K | -2.24M | -70K | -51K | -182K | 40K | -216K | -361K | -1.1M | 631K | 234K | 100K | n/a | 308K | n/a | n/a | -1.73M |
Financial Cash Flow | 17K | 74.87M | 307.8M | 21.55M | 175.07M | -606K | 53.29M | 41K | -31K | 96K | 25K | 176K | 218K | 2.52M | 112.26M | 4.08M | 604K | 200K | 307K | 201K | -445K | 232.85M |
Net Cash Flow | -62.19M | -226.61M | 236.19M | -32.53M | 140.53M | -31.9M | 29.15M | -23.28M | 31.11M | 13.6M | -13.67M | 12.81M | -10.24M | -15.25M | -3.12M | -2.13M | -27.09M | -29.76M | -23.23M | -26.48M | -93.05M | 214.03M |
Free Cash Flow | -25.79M | -38.29M | -23.12M | -53.91M | -35.34M | -31.3M | -24.14M | -23.32M | -21.86M | -30.58M | -24.14M | -28.36M | -24.5M | -24.36M | -18.67M | -19.2M | -30.82M | -24.92M | -18.76M | -17.98M | -17.48M | -18.82M |
Adj. Free Cash Flow | -35.19M | -47.16M | -32.07M | -61.94M | -37.18M | -33.23M | -25.84M | -25.58M | -24.65M | -33.66M | -26.03M | -31.53M | -28.74M | -28.43M | -22.55M | -22.53M | -32.57M | -26.66M | -19.96M | -17.98M | -18.55M | -19.71M |
Maintenance CapEx | -36K | -28K | -40K | -2K | -152K | -231K | -72K | -34K | -9K | -114K | -111K | -465K | -399K | -94K | -321K | -298K | -1.89M | -426K | -395K | -636K | -354K | -311K |
Growth CapEx | -84K | -20K | -274K | -242K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.95M | -1.59M | -773K | n/a | -565K | -860K |
Owner Earnings | -25.71M | -38.27M | -22.84M | -53.66M | -35.34M | -31.3M | -24.14M | -23.32M | -21.86M | -30.58M | -24.14M | -28.36M | -24.5M | -24.36M | -18.67M | -19.2M | -26.88M | -23.33M | -17.98M | -17.98M | -16.92M | -17.96M |
Add to Watchlist
Select watchlists to add or remove VOR